We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




All-In-One CLIA Analyzer to Transform Clinical Diagnostics Landscape

By LabMedica International staff writers
Posted on 12 Jul 2023

An automated, compact, and cost-effective CLIA analyzer combines cutting-edge technology with versatile capabilities to provide a wide range of qualitative and quantitative testing options for analytes in human serum, plasma, whole blood, and urine samples. More...

Anbio Biotechnology (Frankfurt, Germany) has launched the Anbio ADL i1910 all-in-one CLIA analyzer that employs a direct chemiluminescence method based on acridinium ester. This ensures accurate and consistent results across a wide range of applications, including hormone detection, myocardial disease screening, infectious disease diagnostics, or tumor-related antigen analysis. The ADL i1910 delivers a powerful performance and fulfills the varied requirements of modern healthcare professionals. It offers an impressive range of 49 developed assays, enabling qualitative as well as quantitative testing of analytes. The ADL i1910 provides a comprehensive immunodiagnostic solution for healthcare providers to access vital information in an efficient manner.

The ADL i1910 significantly enhances laboratory productivity, thanks to its high throughput of up to 120 tests per hour. With its quick turnaround times, healthcare providers can arrive at timely and informed decisions, eventually improving patient care. Its intuitive graphic user interface coupled with a large color touch screen simplifies operation and shortens the learning curve. It user-friendly design makes it easy to use for experienced professionals and new users alike, thus improving overall efficiency. Designed to occupy minimal space, the ADL i1910 has a small footprint in order to optimize valuable space for other necessary lab equipment, making it ideal for laboratories of all sizes. By offering healthcare providers a cost-effective and comprehensive solution, the Anbio ADL i1910 is expected to transform the clinical diagnostics space.

"Anbio is proud to introduce the ADL i1910, a breakthrough CLIA analyzer that revolutionizes clinical diagnostics," said Jack Davis, Chief Business Officer at Anbio. "With its advanced technology, extensive assay menu, and impressive throughput, the ADL i1910 provides healthcare professionals with a reliable and efficient solution for a wide range of diagnostic applications."

Related Links:
Anbio Biotechnology 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.